Health Catalyst
(NASDAQ) HCAT
Health Catalyst Financials at a Glance
Market Cap
$89.04M
Revenue (TTM)
$311.14M
Net Income (TTM)
$177.97M
EPS (TTM)
$-2.53
P/E Ratio
-0.48
Dividend
$0.00
Beta (Volatility)
1.70 (High)
Dividend
$0.00
Beta (Volatility)
1.70 (High)
Price
$1.09
Volume
7,680
Open
$1.18
Price
$1.09
Volume
7,680
Open
$1.18
Previous Close
$1.09
Daily Range
$1.09 - $1.18
52-Week Range
$1.04 - $5.06
Dividend
$0.00
Beta (Volatility)
1.70 (High)
Price
$1.09
Volume
7,680
Open
$1.18
Previous Close
$1.09
Daily Range
$1.09 - $1.18
52-Week Range
$1.04 - $5.06
HCAT News
HCAT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Health Catalyst
Industry
Health Care Technology
Sector
Health CareEmployees
1,200
CEO
Daniel D. Burton, MBA
Website
www.healthcatalyst.comHeadquarters
South Jordan, UT 84095, US
HCAT Financials
Key Financial Metrics (TTM)
Gross Margin
33%
Operating Margin
-12%
Net Income Margin
-57%
Return on Equity
-58%
Return on Capital
-9%
Return on Assets
-35%
Earnings Yield
-2.08%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$89.04M
Shares Outstanding
73.59M
Volume
7.68K
Short Interest
0.00%
Avg. Volume
843.08K
Financials (TTM)
Gross Profit
$104.13M
Operating Income
$36.10M
EBITDA
$14.40M
Operating Cash Flow
$731.00K
Capital Expenditure
$968.00K
Free Cash Flow
$237.00K
Cash & ST Invst.
$95.73M
Total Debt
$171.24M
Health Catalyst Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$74.68M
-6.2%
Gross Profit
$8.16M
-123.5%
Gross Margin
-10.93%
N/A
Market Cap
$89.04M
N/A
Market Cap/Employee
$59.36K
N/A
Employees
1,500
N/A
Net Income
$91.03M
-340.3%
EBITDA
$44.65M
+1896.9%
Quarterly Fundamentals
Net Cash
$75.51M
-635.6%
Accounts Receivable
$59.13M
+3.4%
Inventory
$0.00
N/A
Long Term Debt
$165.83M
-1.0%
Short Term Debt
$5.41M
-97.7%
Return on Assets
-35.41%
N/A
Return on Invested Capital
-8.74%
N/A
Free Cash Flow
$9.64M
+215.3%
Operating Cash Flow
$9.91M
+381.0%